Missing/wrong data?
Log in to edit
Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignancies
scientific article published on 8 August 2012
Author/s
author: Hagop Kantarjian, Stefan Faderl, Tapan Kadia, Farhad Ravandi, Gautam Borthakur, Jorge Eduardo Cortes, Naval Daver, Guillermo Garcia-Manero, Moshe Talpaz
Work details
Publication date
August 8, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.